Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer.

Cancer Immunol Immunother · 2023 · PMC10025233 · PMID 36308553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the final 26 IHC staining samples, we analyzed in the LUAD, LUSC and overall three groups respectively, and found that the immunotherapy response between the high and low expression groups of CXCR4 did not reach statistical significance (Supplementary Figure 8A–C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.